WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017187131) REOVIRIDAE VACCINE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/187131 International Application No.: PCT/GB2017/050994
Publication Date: 02.11.2017 International Filing Date: 10.04.2017
IPC:
C12N 15/46 (2006.01) ,C12N 7/04 (2006.01) ,C12N 5/10 (2006.01) ,A61K 31/7105 (2006.01) ,A61K 39/15 (2006.01) ,C12N 7/00 (2006.01)
Applicants: LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE[GB/GB]; Keppel Street London WC1E 7HT, GB
Inventors: ROY, Polly; GB
Agent: SYMBIOSIS IP LIMITED; Basepoint Business Centre Vale Business Park, Crab Apple Way Evesham Worcestershire WR111GP, GB
Priority Data:
1607196.126.04.2016GB
Title (EN) REOVIRIDAE VACCINE
(FR) VACCIN CONTRE DES REOVIRIDAE
Abstract: front page image
(EN) The invention relates to an isolated African horse sickness virus (AHSV) ssRNA comprising a plurality of mutations; a complementary cell for replication of a vaccinal viral strain from said ssRNA; a vaccinal viral strain derived from said ssRNA; use of said vaccinal viral strain and/or isolated ssRNA in the vaccination of an animal against an infectionby AHSV; a method of vaccination comprising same; and a pharmaceutical composition comprising said vaccinal viral strain and/or said isolated ssRNA.
(FR) La présente invention concerne un ARNsb isolé du virus de la peste du cheval (AHSV) comprenant une pluralité de mutations ; une cellule complémentaire pour la réplication d'une souche virale vaccinale à partir dudit ARNsb ; une souche virale vaccinale dérivée dudit ARNsb ; l'utilisation de ladite souche virale vaccinale et/ou de l'ARNsb isolé dans la vaccination d'un animal contre une infection par AHSV ; un procédé de vaccination comprenant celui-ci ; et une composition pharmaceutique comprenant ladite souche virale vaccinale et/ou ledit ARNsb isolé.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)